Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages
The North Carolina Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding contract that establishes the licensing rights and obligations regarding intellectual property (IP) developed by the University and used by Gentling, Inc. This agreement governs the use, development, commercialization, and protection of IP assets while outlining the responsibilities of both parties. Keywords: North Carolina Collateral, License Agreement, Gentling, Inc., University of North Texas Health Science Center, Intellectual Property, Licensing Rights, Obligations, Use, Development, Commercialization, Protection, Responsibilities. Different Types of North Carolina Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center: 1. Exclusive Collateral License Agreement: This type of agreement grants Gentling, Inc. exclusive rights to use and commercialize the University's IP, preventing the University from licensing the same IP to any other party. 2. Non-Exclusive Collateral License Agreement: This agreement allows Gentling, Inc. to use and commercialize the University's IP, but the University retains the right to license the same IP to other parties simultaneously. 3. Sublicensing Collateral License Agreement: This type of agreement permits Gentling, Inc. to sublicense the University's IP to third parties for further development, commercialization, or collaboration while still maintaining the primary license agreement with the University. 4. Territory-Specific Collateral License Agreement: This agreement grants Gentling, Inc. the rights to use and commercialize the University's IP within a specific geographic territory, such as North Carolina, while excluding other regions. 5. Reserved Rights Collateral License Agreement: This agreement allows the University to retain specific rights regarding the use, development, and commercialization of its IP, while granting Gentling, Inc. limited rights to use the IP for specific purposes or conditions. 6. Collaborative Collateral License Agreement: This agreement establishes a collaborative partnership between Gentling, Inc. and the University, allowing both parties to jointly develop, commercialize, and share the IP assets based on mutual contributions and obligations. These different types of North Carolina Collateral License Agreements offer flexibility in defining the scope and limitations of the licensing arrangement between Gentling, Inc. and The University of North Texas Health Science Center, depending on the specific needs and objectives of both parties involved.
The North Carolina Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding contract that establishes the licensing rights and obligations regarding intellectual property (IP) developed by the University and used by Gentling, Inc. This agreement governs the use, development, commercialization, and protection of IP assets while outlining the responsibilities of both parties. Keywords: North Carolina Collateral, License Agreement, Gentling, Inc., University of North Texas Health Science Center, Intellectual Property, Licensing Rights, Obligations, Use, Development, Commercialization, Protection, Responsibilities. Different Types of North Carolina Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center: 1. Exclusive Collateral License Agreement: This type of agreement grants Gentling, Inc. exclusive rights to use and commercialize the University's IP, preventing the University from licensing the same IP to any other party. 2. Non-Exclusive Collateral License Agreement: This agreement allows Gentling, Inc. to use and commercialize the University's IP, but the University retains the right to license the same IP to other parties simultaneously. 3. Sublicensing Collateral License Agreement: This type of agreement permits Gentling, Inc. to sublicense the University's IP to third parties for further development, commercialization, or collaboration while still maintaining the primary license agreement with the University. 4. Territory-Specific Collateral License Agreement: This agreement grants Gentling, Inc. the rights to use and commercialize the University's IP within a specific geographic territory, such as North Carolina, while excluding other regions. 5. Reserved Rights Collateral License Agreement: This agreement allows the University to retain specific rights regarding the use, development, and commercialization of its IP, while granting Gentling, Inc. limited rights to use the IP for specific purposes or conditions. 6. Collaborative Collateral License Agreement: This agreement establishes a collaborative partnership between Gentling, Inc. and the University, allowing both parties to jointly develop, commercialize, and share the IP assets based on mutual contributions and obligations. These different types of North Carolina Collateral License Agreements offer flexibility in defining the scope and limitations of the licensing arrangement between Gentling, Inc. and The University of North Texas Health Science Center, depending on the specific needs and objectives of both parties involved.